Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Reed

Showing results (201-210 of 339) with videos related to

Pageof 34
Sort By:
Science (New York, N.Y.)|January 22, 2011
Discovery of a viral NLR homolog that inhibits the inflammasomeSean M Gregory, Beckley K Davis, John A West, et al.
Cancer Letters|September 11, 2008
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonistsJun Wei, Michele F Rega, Shinichi Kitada, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry toolsJeffrey H Price, Angela Goodacre, Klaus Hahn, et al.
Immunity|January 18, 2006
Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpointToru Fukushima, Juan M Zapata, Netai C Singha, et al.
The Journal of Biological Chemistry|July 13, 2005
LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3ShuangDing Wu, Ping Xie, Kate Welsh, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
BAG1 over-expression in brain protects against strokePawel Kermer, Murat H Digicaylioglu, Marcus Kaul, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2012
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovaryDirk Bauerschlag, Karen Bräutigam, Roland Moll, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting BidBarbara Becattini, Carsten Culmsee, Marilisa Leone, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.
Plos One|June 28, 2007
Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphomaChristina L Kress, Marina Konopleva, Vanesa Martínez-García, et al.
Pageof 34

Showing results (201-210 of 339) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|January 22, 2011
Discovery of a viral NLR homolog that inhibits the inflammasomeSean M Gregory, Beckley K Davis, John A West, et al.
Cancer Letters|September 11, 2008
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonistsJun Wei, Michele F Rega, Shinichi Kitada, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry toolsJeffrey H Price, Angela Goodacre, Klaus Hahn, et al.
Immunity|January 18, 2006
Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpointToru Fukushima, Juan M Zapata, Netai C Singha, et al.
The Journal of Biological Chemistry|July 13, 2005
LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3ShuangDing Wu, Ping Xie, Kate Welsh, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
BAG1 over-expression in brain protects against strokePawel Kermer, Murat H Digicaylioglu, Marcus Kaul, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2012
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovaryDirk Bauerschlag, Karen Bräutigam, Roland Moll, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting BidBarbara Becattini, Carsten Culmsee, Marilisa Leone, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.
Plos One|June 28, 2007
Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphomaChristina L Kress, Marina Konopleva, Vanesa Martínez-García, et al.
Pageof 34